Clinical Study of Umbilical Cord Blood Mononuclear Cells (UCB-MNCs) in the Treatment of Traumatic Fracture Healing

Bone Nonunion Clinical Trial

Official title:
Clinical Study of Umbilical Cord Blood Mononuclear Cells (UCB-MNCs) in Promoting Traumatic Fracture Healing

Status Recruiting

Clinical Trial Summary

The aim of this study is to explore the effectiveness and safety of umbilical cord blood mononuclear cells in promoting traumatic fracture healing.

Clinical Trial Description

Umbilical cord blood mononuclear cells are a type of cell group containing hematopoietic stem cells, mesenchymal stem cells, neural stem cells, endothelial cells, immune cells, etc.In this study ,umbilical cord blood mononuclear cells will be used in promoting traumatic fracture healing,and the effectiveness and safety of the treatment plan was evaluated by twelve months of follow-up after treatment. ;

Study Design

Related Conditions & MeSH terms

Clinical Trial Details

NCT number	NCT04997590
Study type	Interventional
Source	Qianfoshan Hospital
Contact	Chunming Zhang, doctor
Phone	+8618663761275
Email	liangjing0531@163.com
Status	Recruiting
Phase	N/A
Start date	December 10, 2020
Completion date	December 10, 2022

View Details

See also
	Status	Clinical Trial	Phase
	Recruiting	`NCT02748343` - The Clinical Therapeutic Effects and Safety of Tissue-engineered Bone	Phase 1/Phase 2
	Not yet recruiting	`NCT02815423` - Safety and Exploratory Efficacy Study of UCMSCs in Patients With Fracture and Bone Nonunion	Phase 1/Phase 2